Halozyme Q4 2025 Earnings Surge: Royalty Revenue Soars 52%
Halozyme Therapeutics Inc. (NASDAQ: HALO) hit record revenue. Full-year 2025 revenue reached $1.4 billion. So this is 38%...
Expert equity analysis, earnings previews, and data-driven market research.
Halozyme Therapeutics Inc. (NASDAQ: HALO) hit record revenue. Full-year 2025 revenue reached $1.4 billion. So this is 38%...
Shares of AtriCure, Inc. (Nasdaq: ATRC) rose 6.4% to $34.12 in Wednesday morning trading after the medical device...
Shares of Beta Bionics, Inc. (Nasdaq: BBNX) were trading modestly higher in late morning U.S. trading on Wednesday,...
Herc Holdings Inc (NYSE: HRI) shares closed at $150.12, up 2.4% intraday at the latest US market close...
Shares of cbdMD, Inc. (NYSE YCBD) rose 10.72% to $0.78 in Tuesday afternoon trading following the release of...
ReposiTrak (NYSE: TRAK), a prominent provider of food traceability and regulatory compliance networks, reported a 13% increase in...
Genmab A/S (Nasdaq: GMAB) released its full-year 2025 financial results, demonstrating the company’s improved operational execution. Total revenue...
Waystar Holding Corp (Nasdaq: WAY) shares closed at $24.29 at the latest U.S. market close following the company’s...
Somnigroup International Inc. (NYSE: SGI) shares declined sharply following the company’s release of fourth-quarter and full-year 2025 financial...
SunCoke Energy, Inc. (NYSE: SXC) reported a net loss for the fourth quarter and full year of 2025,...
Kite Realty Group (NYSE: KRG) delivered impressive Q4 2025 earnings results. FFO totaled $2.10 for the full year...
Vulcan Materials Company (NYSE: VMC) Q4 2025 earnings report is out. The firm is top in rock and...